-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QyYV7C9RH38WbQ4XVUCLGVlNODp6XK1kscOYgdsOM42VlcOIxZ5QmGLPhTzT/OcK i5IIlGpacSNgJNRbB8iyWQ== 0001183740-09-000111.txt : 20090318 0001183740-09-000111.hdr.sgml : 20090318 20090318185741 ACCESSION NUMBER: 0001183740-09-000111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090311 FILED AS OF DATE: 20090318 DATE AS OF CHANGE: 20090318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CORIN DENIS CENTRAL INDEX KEY: 0001405626 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27239 FILM NUMBER: 09692000 MAIL ADDRESS: STREET 1: 4130 BLENHEIM STREET CITY: VANCOUVER STATE: A1 ZIP: V6L 2Z2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TAPIMMUNE INC CENTRAL INDEX KEY: 0001094038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880277072 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UNIT 2 - 3590 WEST 41ST AVENUE CITY: VANCOUVER STATE: A1 ZIP: V6N 3E6 BUSINESS PHONE: 604-264-8274 MAIL ADDRESS: STREET 1: UNIT 2 - 3590 WEST 41ST AVENUE CITY: VANCOUVER STATE: A1 ZIP: V6N 3E6 FORMER COMPANY: FORMER CONFORMED NAME: GENEMAX CORP DATE OF NAME CHANGE: 20020718 FORMER COMPANY: FORMER CONFORMED NAME: EDUVERSE COM DATE OF NAME CHANGE: 19990827 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2009-03-11 0 0001094038 TAPIMMUNE INC TPIM 0001405626 CORIN DENIS 4130 BLENHEIM STREET VANCOUVER A1 V6L 2Z2 BRITISH COLUMBIA, CANADA 0 1 0 0 President and CEO Purchase Warrants 0.01 2009-03-11 4 J 0 150000 0 A 2009-03-11 2009-08-15 Common Stock 150000 150000 D Purchase Warrants 0.01 2009-03-11 4 J 0 200000 0 A 2009-03-11 2010-11-15 Common Stock 200000 350000 D Effective March 11, 2009, the Issuer ratified the issuance of these 150,000 share purchase warrants to the Reporting Person as partial consideration for a loan made by the Reporting Person to the Issuer pursuant to and in accordance with the terms of a promissory note. Effective March 11, 2009, the Issuer ratified the issuance of these 200,000 share purchase warrants to the Reporting Person as partial consideration for a loan made by the Reporting Person to the Issuer pursuant to and in accordance with the terms of a promissory note. As previously reported on a Form 3 filed by the Reporting Person on July 3, 2007, the Reporting Person also holds options to purchase up to an aggregate of 800,000 shares of the Issuer's common stock at an exercise price of $0.25 per share, exercisable until June 8, 2017. /s/ Denis Corin 2009-03-18 -----END PRIVACY-ENHANCED MESSAGE-----